Your browser doesn't support javascript.
loading
Corrigendum to "Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells" [Cancer Lett. 412 (2018) 297-307].
Le, Huong Thuy; Nguyen, Huy Truong; Min, Hye-Young; Hyun, Seung Yeob; Kwon, Soonbum; Lee, Yeongcheol; Van Le, Thi Hong; Lee, Jeeyeon; Park, Jeong Hill; Lee, Ho-Young.
Affiliation
  • Le HT; Creative Research Initiative Center for Concurrent Control of Emphysema and Lung Cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea; College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
  • Nguyen HT; College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
  • Min HY; Creative Research Initiative Center for Concurrent Control of Emphysema and Lung Cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea; Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology and College
  • Hyun SY; Creative Research Initiative Center for Concurrent Control of Emphysema and Lung Cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea; College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
  • Kwon S; College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
  • Lee Y; College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
  • Van Le TH; Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
  • Lee J; College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
  • Park JH; College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
  • Lee HY; Creative Research Initiative Center for Concurrent Control of Emphysema and Lung Cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea; College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea; Department of Molecular Medicine and Biopharmaceu
Cancer Lett ; 568: 216289, 2023 Aug 01.
Article in En | MEDLINE | ID: mdl-37423849
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Lett Year: 2023 Document type: Article Country of publication: Irlanda
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Lett Year: 2023 Document type: Article Country of publication: Irlanda